✓ Last verified: January 18, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: Greenbrook TMS Shoreham is one of multiple Greenbrook locations serving the San Diego metro area, situated near University City and the UTC shopping district. This center offers insurance-covered Spravato (esketamine nasal spray) and NeuroStar TMS therapy for treatment-resistant depression and MDD with suicidal ideation. The Shoreham Place location provides convenient access for patients in La Jolla, University City, Clairemont, and central San Diego neighborhoods seeking FDA-approved depression treatments covered by insurance.
| Google Reviews | ⭐ 4.5 (National Network) |
| Location | San Diego, California |
| Address | 5060 Shoreham Place, Suite 330, San Diego, CA 92122 |
| Phone | (855) 940-4867 |
| Website | greenbrooktms.com |
| Treatments | Spravato (Esketamine Nasal Spray), NeuroStar TMS Therapy |
| Conditions Treated | Treatment-Resistant Depression, MDD with Suicidal Ideation |
| Cost | Covered by most major insurance plans |
| Insurance | Most major insurance accepted for both Spravato and TMS |
| KAP Available | No — Spravato administered under medical supervision (not KAP) |
| Clinical Lead | Greenbrook TMS Clinical Team |
HealingMaps Take: San Diego has a robust ketamine clinic scene, but many are self-pay only. Greenbrook’s Shoreham location stands out specifically for patients who need insurance-covered treatment. The combination of Spravato and TMS gives patients two FDA-cleared modalities to discuss with their provider. The central San Diego location near UTC is easily accessible from multiple neighborhoods. For patients who’ve been priced out of IV ketamine clinics, Greenbrook provides a viable, insurance-covered alternative.
Market Position: Greenbrook TMS (Shoreham) is a Spravato-certified clinic in the Diego metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
⚠ FDA-cleared indications for TMS therapy: treatment-resistant major depressive disorder (MDD), obsessive-compulsive disorder (OCD, Deep TMS only), anxious depression, short-term smoking cessation, and adolescent MDD (ages 15–21). Use of TMS for other conditions including PTSD, bipolar depression, fibromyalgia, and other indications is off-label — not currently FDA-cleared for those specific indications. Discuss your condition with the clinic to understand insurance coverage and clinical evidence.
Industry pricing reference. Greenbrook TMS (Shoreham)’s posted price: Covered by most major insurance plans. Contact the clinic for any package or sliding-scale options. The calculator above shows metro-level cost estimates across protocols.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | — |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
This 2-question summary is matched to the protocols and conditions Greenbrook TMS (Shoreham) treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Yes — Greenbrook TMS (Shoreham) offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
Greenbrook TMS (Shoreham) treats depression via Spravato (FDA-cleared for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
TMS therapy is also available at this clinic, alongside ketamine and Spravato. Unlike cash-pay ketamine, TMS is covered by most major insurance plans for treatment-resistant depression. TMS is FDA-cleared for treatment-resistant depression (since 2008), OCD via Deep TMS, anxious depression, and adolescent MDD ages 15–21. This clinic uses BrainsWay Deep TMS, the only TMS device with standalone FDA clearance for OCD via the H7 coil. Read our complete guide to TMS therapy for FDA-cleared conditions, device differences, insurance coverage by carrier, and what to expect at your first appointment. Browse verified TMS clinics in our directory.
View all REMS-certified Spravato clinics in California and across the United States.
Leave a Reply